AstraZeneca boosts heart, kidney business with $1.8 billion CinCor deal | SaltWire

Retrieved on: 2023-01-09 19:44:40

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca boosts heart, kidney business with $1.8 billion CinCor deal | SaltWire. View article details on hiswai:

Excerpt

By Natalie Grover (Reuters) -AstraZeneca said on Monday it had struck a deal to buy U.S.-based drug developer CinCor Pharma Inc for up to $1.8 ...

Article found on: www.saltwire.com